Senior insider sale
Chief Financial Officer at ARROWHEAD PHARMACEUTICALS, INC. — senior position signals high conviction
$934.2K
13.10K shares
What this filing means
APEL DANIEL JOSEPH plans to sell 13.10K shares of ARROWHEAD PHARMACEUTICALS, INC. valued at approximately $934.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/22/2026ACC: 0001628280-26-026634
Officer· Chief Financial Officer
Since Apr 2025
13.10K
Shares to sell
$934.2K
Approx. market value
100K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Bonus
Compensation
4/15/2025
100KTotal acquired100K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/15/2025 | Bonus Compensation | 100K | — |
| Total | 100K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
13.10K
Market value
$934.2K
4/22/2026
Total
Units
13.10K
Value
$934.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
4/22/2026 | 13.10K | $934.2K | Nasdaq | Planned |
| Total | 13.10K | $934.2K | ||